Related references
Note: Only part of the references are listed.Regulation of podocalyxin expression in the kidney of streptozotocin-induced diabetic rats with Chinese herbs (Yishen capsule)
Jingai Fang et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)
Alteration of Podocyte Protein Expression and Localization in the Early Stage of Various Hemodynamic Conditions
Kai Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Messenger RNA levels of podocyte-associated proteins in subjects with different degrees of glucose tolerance with or without nephropathy
Jonathan Fraportti do Nascimento et al.
BMC NEPHROLOGY (2013)
Cellular and molecular mechanisms of metformin: an overview
Benoit Viollet et al.
CLINICAL SCIENCE (2012)
Urinary podocalyxin is an early marker for podocyte injury in patients with diabetes: establishment of a highly sensitive ELISA to detect urinary podocalyxin
M. Hara et al.
DIABETOLOGIA (2012)
Renal Podocyte Injury in a Rat Model of Type 2 Diabetes Is Prevented by Metformin
Junghyun Kim et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Podocytopathy in Diabetes: A Metabolic and Endocrine Disorder
Ana Diez-Sampedro et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2011)
Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression
Abdulqader A. Alhaider et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2011)
Immunohistochemical evaluation of podocalyxin expression in glomerulopathies associated with nephrotic syndrome
Evangelia Kavoura et al.
HUMAN PATHOLOGY (2011)
Metformin Activates AMP Kinase through Inhibition of AMP Deaminase
Jiangyong Ouyang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus
Ryoichi Takayanagi et al.
JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION (2011)
Metformin induces suppression of NAD(P)H oxidase activity in podocytes
Agnieszka Piwkowska et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)
CIN85/RukL Is a Novel Binding Partner of Nephrin and Podocin and Mediates Slit Diaphragm Turnover in Podocytes
Irini Tossidou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Hepatic Expression Profiling Shows Involvement of PKC Epsilon, DGK eta, Tnfaip, and Rho kinase in type 2 Diabetic Nephropathy Rats
Jeena Gupta et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2010)
Podocalyxin Is a Novel Polysialylated Neural Adhesion Protein with Multiple Roles in Neural Development and Synapse Formation
Nathalia Vitureira et al.
PLOS ONE (2010)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Impaired transcription factor interplay in addition to advanced glycation end products suppress podocalyxin expression in high glucose-treated human podocytes
Garyfalia I. Drossopoulou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Combination therapy with an ACE inhibitor and an angiotensin receptor blocker for diabetic nephropathy: a meta-analysis
D. L. Jennings et al.
DIABETIC MEDICINE (2007)
PPARγ agonists partially restores hyperglycemia induced aggravation of vascular dysfunction to angiotensin II in thoracic aorta isolated from rats with insulin resistance
Anil Bhanudas Gaikwad et al.
PHARMACOLOGICAL RESEARCH (2007)
Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies
JG van den Berg et al.
KIDNEY INTERNATIONAL (2004)
Share Paper
